Annual D&A
$3.75 M
+$453.40 K+13.77%
31 December 2023
Summary:
SAB Biotherapeutics annual depreciation & amortization is currently $3.75 million, with the most recent change of +$453.40 thousand (+13.77%) on 31 December 2023. During the last 3 years, it has risen by +$3.20 million (+583.20%). SABS annual D&A is now at all-time high.SABS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$966.90 K
-$88.40 K-8.38%
30 September 2024
Summary:
SAB Biotherapeutics quarterly depreciation & amortization is currently $966.90 thousand, with the most recent change of -$88.40 thousand (-8.38%) on 30 September 2024. Over the past year, it has dropped by -$18.50 thousand (-1.88%). SABS quarterly D&A is now -51.28% below its all-time high of $1.98 million, reached on 31 March 2024.SABS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$4.95 M
-$18.50 K-0.37%
30 September 2024
Summary:
SAB Biotherapeutics TTM depreciation & amortization is currently $4.95 million, with the most recent change of -$18.50 thousand (-0.37%) on 30 September 2024. Over the past year, it has increased by +$1.23 million (+32.94%). SABS TTM D&A is now -0.37% below its all-time high of $4.97 million, reached on 30 June 2024.SABS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SABS Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.8% | -1.9% | +32.9% |
| 3 y3 years | +583.2% | +133.0% | +399.0% |
| 5 y5 years | - | - | - |
SABS Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +583.2% | -51.3% | +133.0% | -0.4% | +399.0% |
| 5 y | 5 years | at high | +1058.1% | -51.3% | +248.8% | -0.4% | +1686.2% |
| alltime | all time | at high | +1058.1% | -51.3% | +248.8% | -0.4% | +1686.2% |
SAB Biotherapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $966.90 K(-8.4%) | $4.95 M(-0.4%) |
| June 2024 | - | $1.06 M(-46.8%) | $4.97 M(+3.4%) |
| Mar 2024 | - | $1.98 M(+110.2%) | $4.81 M(+28.3%) |
| Dec 2023 | $3.75 M(+13.8%) | $944.40 K(-4.2%) | $3.75 M(+0.6%) |
| Sept 2023 | - | $985.40 K(+10.4%) | $3.72 M(+2.1%) |
| June 2023 | - | $892.30 K(-3.3%) | $3.65 M(+3.1%) |
| Mar 2023 | - | $923.20 K(-0.0%) | $3.54 M(+7.5%) |
| Dec 2022 | $3.29 M | $923.50 K(+1.5%) | $3.29 M(+8.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $909.90 K(+16.5%) | $3.03 M(+19.5%) |
| June 2022 | - | $781.00 K(+15.3%) | $2.53 M(+23.4%) |
| Mar 2022 | - | $677.40 K(+2.5%) | $2.05 M(+24.2%) |
| Dec 2021 | $1.65 M(+201.6%) | $661.20 K(+59.3%) | $1.65 M(+66.6%) |
| Sept 2021 | - | $415.00 K(+38.3%) | $992.30 K(+71.9%) |
| June 2021 | - | $300.10 K(+8.3%) | $577.30 K(+108.3%) |
| Mar 2021 | - | $277.20 K | $277.20 K |
| Dec 2020 | $548.20 K(+69.5%) | - | - |
| Dec 2019 | $323.40 K | - | - |
FAQ
- What is SAB Biotherapeutics annual depreciation & amortization?
- What is the all time high annual D&A for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual D&A year-on-year change?
- What is SAB Biotherapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly D&A year-on-year change?
- What is SAB Biotherapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for SAB Biotherapeutics?
- What is SAB Biotherapeutics TTM D&A year-on-year change?
What is SAB Biotherapeutics annual depreciation & amortization?
The current annual D&A of SABS is $3.75 M
What is the all time high annual D&A for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual depreciation & amortization is $3.75 M
What is SAB Biotherapeutics annual D&A year-on-year change?
Over the past year, SABS annual depreciation & amortization has changed by +$453.40 K (+13.77%)
What is SAB Biotherapeutics quarterly depreciation & amortization?
The current quarterly D&A of SABS is $966.90 K
What is the all time high quarterly D&A for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly depreciation & amortization is $1.98 M
What is SAB Biotherapeutics quarterly D&A year-on-year change?
Over the past year, SABS quarterly depreciation & amortization has changed by -$18.50 K (-1.88%)
What is SAB Biotherapeutics TTM depreciation & amortization?
The current TTM D&A of SABS is $4.95 M
What is the all time high TTM D&A for SAB Biotherapeutics?
SAB Biotherapeutics all-time high TTM depreciation & amortization is $4.97 M
What is SAB Biotherapeutics TTM D&A year-on-year change?
Over the past year, SABS TTM depreciation & amortization has changed by +$1.23 M (+32.94%)